Business
Johnson and Johnson delays COVID-19 antibody preliminary after ‘unexplained disease’s
Drugmaker Johnson and Johnson said Monday it has delayed the serious clinical preliminary of its trial Covid immunization in view of an unexplained ailment in one of the volunteers. “Following our rules, the member’s ailment is being explored and assessed by the ENSEMBLE autonomous Data Safety Monitoring Board (DSMB) just Read more…